Meetings and Education

Section Menu  


Sexual and Gender Minorities/LGBTQ+ Issues in RO

Wednesday, June 30, 2021 | 6:00 p.m. - 7:00 p.m Eastern time

Watch this conversation on the issues around sexual and gender minorities and LGBTQ+ issues in radiation oncology.  



Session Sources
  • Burns, Z. T., Bitterman, D. S., Liu, K. X., Terezakis, S. A., Neira, P. M., & Haas-Kogan, D. A. (2019). Towards a standard of care in oncology for transgender patients. The Lancet Oncology, 20(3), 331-333.

  • Burns, Z. T., Bitterman, D. S., Perni, S., Boyle, P. J., Guss, C. E., Haas-Kogan, D. A., & Liu, K. X. (2021). Clinical characteristics, experiences, and outcomes of transgender patients with cancer. JAMA oncology, 7(1), e205671-e205671.

  • Griggs, J., Maingi, S., Blinder, V., Denduluri, N., Khorana, A. A., Norton, L., ... & Rowland, J. H. (2017). American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. Obstetrical & Gynecological Survey, 72(10), 598-599.

  • Fliesler, N. (2021). Cancer in transgender patients: Care considerations. Boston Children's Answers. https://answers.childrenshospital.org/cancer-transgender/.



Shilpen Patel

Shilpen Patel, MD, FASTRO
Sutter Health

Shilpen Patel is a radiation oncologist who is currently practicing at Sutter Health in Northern California and is the principal health equity and inclusive research medical director at Genentech. He is affiliated with the University of Washington Department of Global Health and the Fred Hutchinson Cancer Research Center's Division of Public Health. In the past he has worked in a variety of settings including academic medicine, working in the startup space, in global health and as director of a nonprofit for statewide initiatives. In radiation oncology he has served as chair of ARRO, served various roles in the Government Relations Council, as chair of the Alternative Payment Model, working on the Maintenance of Certification Committee, working in the Radiation and Cancer Biology Committee and currently on CHEDI. He has a long history of working in civil rights and has served on the boards of Equal Rights Washington, the National LGBTQ Task Force and the Horizons Foundation. He also currently serves on the AMA Foundation’s LGBTQ+ Fellowship Commission and as immediate past chair of the AMA’s LGBTQ Advisory Committee and Young Physician Section. He was just named as #3 in Yahoo’s global OUTstanding top 100 LGBTQ+ FUTURE LEADERS.
Jessica Halem

Jessica Halem, MBA
LGBTQ+ Consultant

Jessica Halem is an award-winning lesbian with accolades from GLMA, Harvard and The Advocate magazine. She was the LGBTQ Director at Harvard Medical School where she grew the student body from 4% to 15% LGBTQ and the OutList to over 350. While at Harvard, Jessica secured a $1.5 million dollar grant to integrate sexual and gender minority health into the curriculum. Earlier, Jessica ran the Lesbian Community Cancer Project in Chicago where she implemented the first cultural competency trainings for the CDC and served on then-candidate Obama’s first LGBT Advisory Committee. Jessica has published on transgender health, optimism and mentoring.
Daphne Haas-Kogen

Daphne Haas-Kogen, MD, FASTRO
Dana-Farber Cancer Institute

Daphne Haas-Kogan is Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Boston Children’s Hospital. She is the Willem and Corrie Hees Family Professor of Radiation Oncology at Harvard Medical School.

Dr. Haas-Kogan received an undergraduate degree in Biochemistry and Molecular Biology from Harvard University. She received her MD from the University of California, San Francisco, and completed her residency in radiation oncology and post-doctoral fellowship in molecular neuro-oncology at UCSF in 1997. She remained at UCSF as a tenure track faculty member with joint appointments in radiation oncology and neurological surgery, was Vice-Chair for Research since 2003, and Educational Program Director since 2008.

In 2015, Dr. Haas-Kogan was appointed Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Boston Children’s Hospital.

Dr. Haas-Kogan has been the principal investigator on many grants funded by NIH/NCI, philanthropic organizations, and industry collaborations. She has focused much of her laboratory investigations, translational science and clinical trials on targeted and biologic agents for the treatment of pediatric cancers.

Dr. Haas-Kogan’s recent national activity has included participation in:

  • The Blue Ribbon Panel of scientific experts for the National Cancer Moonshot Initiative
  • Association of American Physicians (AAP) Honorary Medical Society
  • The National Academy of Medicine
  • Delivering the Annual Oration in Radiation Oncology Plenary Speaker at the Radiological Society of North America Meeting (in 2017).
Carl Streed Jr.

Carl Streed Jr., MD, MPH
Boston University School of Medicine

Carl Streed Jr., is an Assistant Professor in the Boston University School of Medicine. After attending medical school and residency in internal medicine at Johns Hopkins, he completed a fellowship in general internal medicine at Brigham and Women’s. Nationally, he has chaired the American Medical Association Advisory Committee on LGBTQ Issues, served on the board of GLMA: Health Professionals Advancing LGBTQ Equality and currently serves on the board of the U.S. Professional Association for Transgender Health. Carl’s efforts to improve the health and well-being of sexual and gender minority individuals and communities have earned him several awards, notably from the University of Chicago and Johns Hopkins University Alumni Associations, the American Medical Association Foundation, the World Professional Association for Transgender Health, as well as recognition from the Obama White House. As the Research Lead for the Center for Transgender Medicine and Surgery at Boston Medical Center he collaborates with researchers, physicians and staff to assess and address the health and well-being of transgender and gender diverse individuals.
Copyright © 2024 American Society for Radiation Oncology